Narnatumab
Narnatumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Narnatumab is under investigation in clinical trial NCT01119456 (A Study of IMC-RON8 in Advanced Solid Tumors).
| Trade Name | Narnatumab |
| Generic | Narnatumab |
| Narnatumab Other Names | Narnatumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Narnatumab
